No Data
Yihe Jiaye: First quarter report 2025
Jihe Jiaye: 2024 Annual Report Summary
Jiehe Jiaye: Annual Report 2024
Jardine Matheson (301367.SZ): Net income for the year 2024 is 0.155 billion yuan, proposing a dividend of 4 yuan per share.
Glory Financial reported on April 17 that Yihe Jiaye (301367.SZ) published its annual report for 2024, achieving revenue of 0.843 billion yuan, a year-on-year decrease of 24.85%; net income attributable to shareholders of the listed company was 0.155 billion yuan, a year-on-year decrease of 47.74%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 92.4634 million yuan, a year-on-year decrease of 61.79%; basic EPS was 1.74 yuan; plans to distribute a cash dividend of 4 yuan (tax included) for every 10 shares to all shareholders.
Yihe Jiaye (301367.SZ): Plans to change the company name, stock abbreviation, and revise the "Articles of Association".
On April 17, Gelonghui reported that Yihe Jiaye (301367.SZ) announced that in order to adapt to the company's expanding scale, number of talents, and scope of Business, the company is continuously promoting the optimization and upgrade of its organizational structure aimed at meeting market demand. To more accurately reflect the company's future development positioning, the company intends to change its Chinese name and stock abbreviation, while the English name and stock code will remain unchanged. The Chinese name is intended to be changed to Peking Ruimai Te Medical Technology Co., Ltd., and the stock abbreviation is intended to be changed to Ruimai Te. The company intends to update the corresponding basic information in the "Articles of Association of Peking Yihe Jiaye Medical Technology Co., Ltd.".
BMC Medical Co., Ltd.'s (SZSE:301367) CEO Zhi Zhuang Is the Most Upbeat Insider, and Their Holdings Increased by 9.6% Last Week